Rigel Pharmaceuticals EPS Diluted from Extraordinaries (Quarterly) Insights

Rigel Pharmaceuticals, Inc. (RIGL)

35.46 -1.18 (-3.22%) USD | NASDAQ | Feb 20, 16:00

35.45 -0.01 (-0.03%) Pre-Market: 20:00

View EPS Diluted from Extraordinaries (Quarterly) for RIGL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Extraordinaries (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Extraordinaries (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Extraordinaries (Quarterly) Benchmarks

Start Trial

Nektar Therapeutics	--
Eli Lilly & Co.	--
Ironwood Pharmaceuticals, Inc.	--
BioMarin Pharmaceutical, Inc.	--
Catalyst Pharmaceuticals, Inc.	--